Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression

Autor: Vráblová, Lucia, Klamová, Hana, Skoumalová, Ivana, Navrátilová, Jana, Janská, Romana, Grohmann, Jan, Holzerová, Milena, Faber, Edgar
Zdroj: In Hematology, Transfusion and Cell Therapy March 2024
Databáze: ScienceDirect